课题基金 / 基金详情

ALDOSE REDUCTASE GENE EXPRESSION IN DIABETIC COMPLICATIONS

ALDOSE REDUCTASE GENE EXPRESSION IN DIABETIC COMPLICATIONS
糖尿病并发症中醛糖还原酶基因的表达
批准号:
6244587
负责人:
DOUGLAS N HENRY
金额:
$2.22万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-02-20 至 1997-11-30

项目摘要

项目成果

DOUGLAS N HENRY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The overall aim of this application is to characterize the mechanism(s) regulating aldose reductase (AR2,EC1.1.1.21) gene expression in cells from tissues involved in the complications of diabetes, and to determine the basis for abnormal constitutive over-expression of AR2 by a line of human retinal pigment epithelial (RPE) cells. The rationale for this proposal rests on the postulated role of AR2 in the genesis of the chronic complications of diabetes, and the growing evidence that AR2 particpates in, and is modulated by, physiological osmoregulation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ALDOSE REDUCTASE EXPRESSION IN DIABETES
  • 批准号:
    2391249
  • 项目类别:
  • 资助金额:
    $8.92万
  • 财政年份:
    1993
  • 负责人:
    DOUGLAS N HENRY
  • 依托单位:
ALDOSE REDUCTASE EXPRESSION IN DIABETES
ALDOSE REDUCTASE EXPRESSION IN DIABETES
ALDOSE REDUCTASE EXPRESSION IN DIABETES
  • 批准号:
    2133989
  • 项目类别:
  • 资助金额:
    $8.92万
  • 财政年份:
    1993
  • 负责人:
    DOUGLAS N HENRY
  • 依托单位:
海外基金